Skip to content

The effectiveness and safety of a multimodal analgesia centered on ultrasound-guided thoracic peripheral nerve block for postoperative analgesia in patients undergoing video-assisted thoracoscopic surgery surgery

The effectiveness and safety of a multimodal analgesia centered on ultrasound-guided thoracic peripheral nerve block for postoperative analgesia in patients undergoing video-assisted thoracoscopic surgery surgery - Thoracic peripheral nerve block for postoperative analgesia in patients undergoing VATS

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079524
Enrollment
Unknown
Registered
2024-01-05
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung diseases

Interventions

Group E:Preoperative ultrasound-guided ESPB and a postoperative multimodal analgesic regimen including sufentanil PCIA, i.v. dexmedetomidine, ibuprofen and dezocine.
Group T:Preoperative ultrasound-guided TPVB and a postoperative multimodal analgesic regimen including sufentanil PCIA, i.v. dexmedetomidine, ibuprofen and dezocine.
Group C:and a postoperative multimodal analgesic regimen including sufentanil PCIA, i.v. dexmedetomidine, ibuprofen and dezocine.

Sponsors

Beijing Children's Hospital, National Center for Children's Health, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 18 Years

Inclusion criteria

Inclusion criteria: Age: 7-18 years old; Scheduled for VATS under general anesthesia; ASA physical status of I-II.

Exclusion criteria

Exclusion criteria: Failure to sign informed consent; Had contraindications to TPVB (vertebral anomalies, scoliosis, coagulopathy, local infection at planned injection sites, or receiving anticoagulation medication); Severe cardiopulmonary dysfunction, hepatic or renal insufficiency; allergy to any medication used in the study; obesity; chronic pain characterized or opioid use for over 3 months preoperatively; unable to cooperate in the pain assessment; psychiatric disorders or taking psychiatric medications; did not have a guardian able to use the parent-controlled intravenous analgesia (PCIA) pump.

Design outcomes

Primary

MeasureTime frame
Postoperative 24 h sufentanil PCIA consumption;

Secondary

MeasureTime frame
Numeric rating scale (NRS) at different postoperative time points;Sufentanil PCIA consumption at different postoperative time points;Rescue analgesia;Postoperative recovery status;Postoperative complications;Length of hospital stay;Ropivacaine blood concentration;

Countries

CHINA

Contacts

Public ContactJIANMIN ZHANG

Beijing Children's Hospital, National Center for Children's Health, Capital Medical University

zhangjianmin@bch.com.cn+86 10 5961 6453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026